Skip to content

Released May 7, 2015, before the open

10-Q filed May 7, 2015, 37 days after period end · 0001144204-15-028164

Q1 2015 · 10-Q
Revenue—
Net Income-$2.96MN/M vs Q1 2014N/M vs Q4 2014
EPS Diluted-$0.23N/M vs Q1 2014no prior Q4 2014 on file
Operating Income-$2,974,239N/M
Operating Cash Flow-$3,025,238N/M
Free Cash Flowderived-$3,038,468N/M

What the release said

The release

Same quarter

MetricQ1 2015Q1 2014Q1 2013Q1 2012
Net Income-$2.96M-$5.27M-$1.35M-$61.23K
EPS Diluted-$0.23-$0.41-$0.30-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR